Furthermore, we demonstrated that loss of the MHC II pathway in the ALS KOs was due to downregulation of CIITA (Class II Major Histocompatibility Complex Transactivator), the master transcriptional regulator of this pathway. The gene discussed is CIITA; the disease is amyotrophic lateral sclerosis.